Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Deucravacitinib Impurity
Deucravacitinib Impurity
  • Deucravacitinib Impurity
  • Deucravacitinib Impurity
  • Deucravacitinib Impurity
  • Deucravacitinib Impurity
  • Deucravacitinib Impurity

Deucravacitinib Impurity NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-07-31

Product Details

Product Name: Deucravacitinib Impurity CAS No.: 2222717-52-2
Min. Order: 10mg Purity: 99%+ HPLC
Supply Ability: 1000 Release date: 2025/07/31

Deucravacitinib Impurity ; 2222717-52-2

Article illustration


Product Information

  • Product Code:D084003

  • English Name:Deucravacitinib Impurity 3

  • English Alias:2-methoxy-3-(1-methyl-1H-1,2,4-triazol-5-yl)aniline

  • CAS No.:2222717-52-2

  • Molecular Formula:C₁₀H₁₂N₄O

  • Molecular Weight:204.23

Advantages

  • High-Purity Reference Standard:Confirmed by HPLC (≥99.0%), NMR (1H, 13C), HRMS, and elemental analysis, suitable for Deucravacitinib impurity analysis and quality control.

  • Stability Assurance:Stable for 36 months at -20℃ under light-protected, sealed storage; degradation rate <0.3% in acetonitrile-water solution within 6 months.

Applications

  • Quality Control Testing:Used for UPLC-MS/MS detection of Impurity 3 in Deucravacitinib API and formulations, controlling content to meet ICH Q3A standards (single impurity limit ≤0.1%).

  • Process Optimization Research:Monitors Impurity 3 formation during Deucravacitinib synthesis, reducing generation by >40% by adjusting reduction temperature (e.g., 50-60℃) and reaction time.

  • Method Validation:Serves as a standard for developing impurity detection methods, verifying UPLC resolution (≥3.0) and LOD (0.01 ng/mL).

Background Description

Deucravacitinib, an oral tyrosine kinase 2 (TYK2) inhibitor, is used for treating autoimmune diseases like psoriasis. Impurity 3, as a process-related impurity of Deucravacitinib, may originate from side products of nitro reduction or amination during triazole ring synthesis. Its amino and triazole groups may affect drug stability and target binding ability. With stricter FDA and EMA requirements for impurities in innovative drugs, studying Impurity 3 is crucial for ensuring drug quality.

Research Status

  • Detection Technology:UPLC-MS/MS with C18 column (1.7μm) and 0.1% formic acid-acetonitrile gradient elution achieves separation within 4 minutes, with LOD of 0.005 ng/mL for trace impurity analysis.

  • Formation Mechanism:Formed by reduction of 2-methoxy-3-(1-methyl-1H-1,2,4-triazol-5-yl)nitrobenzene under palladium-carbon catalysis; optimizing catalyst dosage and hydrogen pressure inhibits side reactions.

  • Safety Evaluation:In vitro cytotoxicity shows IC₅₀ of 192.3 μM against HaCaT cells (Deucravacitinib IC₅₀=11.5 μM), with lower toxicity than the main drug but requiring strict content control. Long-term stability testing is ongoing to monitor degradation under different humidity, light, and temperature conditions.


WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com


NOTE!

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com


NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery! 



Company Profile Introduction

-

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/1g
VIP2Y
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
2024-07-03
$0.00/10g
Cangzhou Kangrui Pharma Tech Co. Ltd.,
2024-12-02
$61.00/1mg
VIP4Y
TargetMol Chemicals Inc.
2025-11-10
INQUIRY